AGIOS PHARMACEUTICALS, INC.
SEC Filing List
AGIO CIK: 0001439222
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | ADVISER COMPLIANCE ASSOCIATES LLC /fa | 05/15/2026 | |||
| SCHEDULE 13G | SCHULTE ROTH & ZABEL LLP /fa | 05/06/2026 | |||
| 8-K | Current report filing | Agios Pharmaceuticals, Inc. | 04/29/2026 | ||
| 10-Q | Quarterly report pursuant to Section 13 ... | Agios Pharmaceuticals, Inc. | 04/29/2026 | ||
| SCHEDULE 13G | 04/29/2026 | ||||
| DEF 14A | Definitive proxy statements | Agios Pharmaceuticals, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/24/2026 | |
| ARS | Annual report to security holders | Agios Pharmaceuticals, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/24/2026 | |
| DEFA14A | Definitive additional proxy soliciting m... | Agios Pharmaceuticals, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/24/2026 | |
| 4 | Statement of changes in beneficial owner... | Viswanadhan Krishnan | Agios Pharmaceuticals, Inc. | 04/06/2026 | |
| 4 | Statement of changes in beneficial owner... | Jones Cecilia | Agios Pharmaceuticals, Inc. | 04/06/2026 | |
| No record found. | |||||
| Load More | |||||
